Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew D Zimmerman

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Nature Medicine|September 8, 2015
The association between sterilizing activity and drug distribution into tuberculosis lesionsBrendan Prideaux, Laura E Via, Matthew D Zimmerman, et al.
Journal of Medicinal Chemistry|January 17, 2025
Metabolically Stable Adenylation Inhibitors of Biotin Protein Ligase as Antibacterial AgentsQiang Liu, Curtis A Engelhart, Joshua B Wallach, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2025
Structure-Guided Development of a Potent BioA Inhibitor Validates Biotin Synthesis Inhibition as a Therapeutic Strategy for TuberculosisQiang Liu, Joshua B Wallach, Yahani P Jayasinghe, et al.
Journal of Medicinal Chemistry|March 4, 2025
Evolution of Small Molecule Inhibitors of <i>Mycobacterium tuberculosis</i> Menaquinone BiosynthesisPankaj Sharma, Quan Jiang, Shao-Gang Li, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
Identification of Antituberculars with Favorable Potency and Pharmacokinetics through Structure-Based and Ligand-Based ModelingVedang Warapande, Fanwang Meng, Alexandra Bozan, et al.
ACS Infectious Diseases|June 19, 2015
Host-Mediated Bioactivation of Pyrazinamide: Implications for Efficacy, Resistance, and Therapeutic AlternativesLaura E Via, Rada Savic, Danielle M Weiner, et al.
Antimicrobial Agents and Chemotherapy|January 31, 2022
A Rabbit Model to Study Antibiotic Penetration at the Site of Infection for Nontuberculous Mycobacterial Lung Disease: Macrolide Case StudyFirat Kaya, Jacqueline P Ernest, Katherine LoMauro, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 30, 2020
State-of-the-Art Data Management: Improving the Reproducibility, Consistency, and Traceability of Structural Biology and in Vitro Biochemical ExperimentsDavid R Cooper, Marek Grabowski, Matthew D Zimmerman, et al.
Cell Chemical Biology|November 13, 2019
Antitubercular Triazines: Optimization and Intrabacterial MetabolismXin Wang, Daigo Inoyama, Riccardo Russo, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 5, 2022
Chemical-genetic interaction mapping links carbon metabolism and cell wall structure to tuberculosis drug efficacyEun-Ik Koh, Peter O Oluoch, Nadine Ruecker, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Nature Medicine|September 8, 2015
The association between sterilizing activity and drug distribution into tuberculosis lesionsBrendan Prideaux, Laura E Via, Matthew D Zimmerman, et al.
Journal of Medicinal Chemistry|January 17, 2025
Metabolically Stable Adenylation Inhibitors of Biotin Protein Ligase as Antibacterial AgentsQiang Liu, Curtis A Engelhart, Joshua B Wallach, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2025
Structure-Guided Development of a Potent BioA Inhibitor Validates Biotin Synthesis Inhibition as a Therapeutic Strategy for TuberculosisQiang Liu, Joshua B Wallach, Yahani P Jayasinghe, et al.
Journal of Medicinal Chemistry|March 4, 2025
Evolution of Small Molecule Inhibitors of <i>Mycobacterium tuberculosis</i> Menaquinone BiosynthesisPankaj Sharma, Quan Jiang, Shao-Gang Li, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
Identification of Antituberculars with Favorable Potency and Pharmacokinetics through Structure-Based and Ligand-Based ModelingVedang Warapande, Fanwang Meng, Alexandra Bozan, et al.
ACS Infectious Diseases|June 19, 2015
Host-Mediated Bioactivation of Pyrazinamide: Implications for Efficacy, Resistance, and Therapeutic AlternativesLaura E Via, Rada Savic, Danielle M Weiner, et al.
Antimicrobial Agents and Chemotherapy|January 31, 2022
A Rabbit Model to Study Antibiotic Penetration at the Site of Infection for Nontuberculous Mycobacterial Lung Disease: Macrolide Case StudyFirat Kaya, Jacqueline P Ernest, Katherine LoMauro, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 30, 2020
State-of-the-Art Data Management: Improving the Reproducibility, Consistency, and Traceability of Structural Biology and in Vitro Biochemical ExperimentsDavid R Cooper, Marek Grabowski, Matthew D Zimmerman, et al.
Cell Chemical Biology|November 13, 2019
Antitubercular Triazines: Optimization and Intrabacterial MetabolismXin Wang, Daigo Inoyama, Riccardo Russo, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 5, 2022
Chemical-genetic interaction mapping links carbon metabolism and cell wall structure to tuberculosis drug efficacyEun-Ik Koh, Peter O Oluoch, Nadine Ruecker, et al.
Pageof 9